Contact Us

Physicians of the Greater Metropolitan Orthopaedic Institute have joined MedStar Orthopaedic Institute

We are pleased to announce that effective April 1, 2014 the physicians of the Greater Metropolitan Orthopaedic Institute have joined MedStar Orthopaedic Institute, which provides exceptional orthopaedic care across the Greater Washington region. In addition, our therapy practices have become part of the MedStar NRH Rehabilitation Network (MedStar NRH), one of the top rehabilitation providers in the country with more than 40 locations in D.C., Maryland and Northern Virginia. Together, we are committed to providing you with exceptional, personalized care.

Management &

Rheumatism &
Arthritis Services

Physical and
Occupational Therapy

James C. Roberson, II, M.D.

Terrence X. Dwyer, M.D.

Infusion Therapy Treatment in Maryland, Washington DC, and Virginia

Infusion Therapy



The development of a center for infusible medications
is practical and paramount for 21st century physicians.
The evolution of treatment options for various disease
processes has not only involved newer mechanisms of
action, but newer modalities of delivery. Many of the
newer pharmacologic agents have taken into account
the number of medications patients take, the variability
of absorption of these medications and the ease of delivery
of current medications. With this in mind, studies have
supported the delivery of certain medications by infusion
or injection to be equally efficacious, if not superior,
as oral regimens.

Injection and/or infusible medications increase patient
compliance by cutting down on the number of oral
medications taken and removing the variable of forgetfulness
in medication regimens. This method of deliver also allows
the physician to directly assess a patient’s compliance and
tolerance of an agent. At GMOI, our infusion center allows
on-site surveillance of our patients being treated with state of the art medications for Lupus, Rheumatoid Arthritis, Osteoporosis, Vasculitis, Crohn’s and Ulcerative Colitis just to name a few. Given their preference, most patients would prefer to be treated in the presence of their physician in the company of people under treatment with “like” illness.